CoChat

Antifibrotic Activity of Bevacizumab on Human Tenon's Fibroblasts In Vitro

O'Neill, Evelyn C., Qin, Queena, Van Bergen, Nicole J., Connell, Paul P., Vasudevan, Sushil, Coote, Michael A., Trounce, Ian A., Wong, Tina T. L., Crowston, Jonathan G. · 2010 · Investigative Opthalmology & Visual Science

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

PURPOSE: To evaluate the effect of the anti-VEGF-A monoclonal antibody bevacizumab on primary human Tenon's capsule fibroblasts (HTFs) in an in vitro model of wound healing. METHODS: Fibroblasts were cultured in RPMI media, and bevacizumab was administered at a concentration ranging from 0.25 to 12.5 mg/mL. Fibroblast viability and cell death were assessed using the MTT colorimetric assay, lactate dehydrogenase assay, BrdU assay, and live/dead assay. Fibroblast contractility was assessed in floating collagen gels. Morphologic changes were assessed by transmission electron microscopy. Antifibrosis activities were compared with 5-fluorouracil. RESULTS: Bevacizumab induced a significant dose-related reduction of HTF cell number at 12.5 mg/mL at 72 hours (P < 0.05). Under serum-free conditions, bevacizumab induced significant fibroblast cell death at concentrations greater than 7.5 mg/mL (P < 0.05). Bevacizumab caused a moderate inhibition of fibroblast gel contraction from baseline (P < 0.05). Scanning electron microscopy revealed marked vacuolization in bevacizumab-treated fibroblasts. CONCLUSIONS: Bevacizumab disrupted fibroblast proliferation, inhibited collagen gel contraction ability, and induced fibroblast cell death at concentrations greater than 7.5 mg/mL in serum-free conditions. These results demonstrated that bevacizumab inhibited a number of fibrosis activities in culture. These activities may underpin the antifibrosis effect proposed in vivo.

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.10-5669

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Cited by

Metadata

Authors
O'Neill, E. C., Qin, Q., Van Bergen, N. J., Connell, P. P., Vasudevan, S., Coote, M. A., Trounce, I. A., Wong, T. T. L., & Crowston, J. G.
Affiliations
  • From the Centre for Eye Research Australia, the Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia;
  • The Royal Victorian Eye & Ear Hospital (AU)
  • Singapore National Eye Center (SG)
Corresponding author
  • Qin, Queena
  • Connell, Paul P.
  • Vasudevan, Sushil
  • Coote, Michael A.
  • Trounce, Ian A.
  • Wong, Tina T. L.
  • Crowston, Jonathan G.
Venue
Investigative Opthalmology & Visual Science
Published
2010-12-01
Volume
51
Issue
12
Pages
6524
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2017909699
Cited by
73
References
44
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 8 · 2014: 6 · 2013: 10 · 2012: 9
FWCI
5.98
Type
journal article
Language
en
Open access
closed
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Corneal Surgery and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
Keywords
bevacizumab, Tenon's capsule fibroblasts, antifibrotic activity, VEGF-A, fibroblast proliferation, collagen gel contraction, wound healing, vacuolization, 5-fluorouracil, ocular fibrosis
MeSH terms
Bevacizumab, Antibodies, Monoclonal, Cell Count, Cells, Cultured, DNA, Dose-Response Relationship, Drug, Fibroblasts, Humans, L-Lactate Dehydrogenase, Microscopy, Electron, Microscopy, Fluorescence, Wound Healing, Apoptosis, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Cell Proliferation, Tenon Capsule, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.